The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

The FDA plans to “rapidly make available” rare disease drugs and make use of surrogate endpoints to get promising medicines ...

Vinay Prasad, a critic of the Food and Drug Administration, has been tapped as the agency’s top regulator of vaccines, gene therapies and the blood supply.

Dr. Vinay Prasad, a vocal critic of the agency's moves to greenlight COVID-19 vaccine boosters. Prasad replaces Dr. Peter Marks, who served as the director of the Center for Biologics Evaluation ...

Vinay Prasad has worked as a professor of medicine ... He steps into the shoes vacated by Peter Marks, who resigned from the role a few weeks ago – reportedly before being pushed out ...

The Food and Drug Administration (FDA) has tapped Vinay Prasad ... to lead the agency’s vaccines division. Prasad replaces Peter Marks, the longtime leader of the Center for Biologics Evaluation ...

WASHINGTON — Vinay Prasad, an academic and fierce critic ... Prasad replaces former CBER director Peter Marks, who was forced to resign by health secretary Robert F. Kennedy Jr. in March.

Vinay Prasad, MD, MPH, a frequent critic of the ... Francisco (UCSF), who has not worked for the FDA before, replaces Peter Marks, MD, PhD, who was forced out of the position in March after ...

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation ...